Annual report pursuant to Section 13 and 15(d)

Fair Value of Financial Instruments - Schedule of Financial Instruments Measured at Fair Value (Details)

v3.23.1
Fair Value of Financial Instruments - Schedule of Financial Instruments Measured at Fair Value (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Liabilities:    
Private warrants $ 1,314 $ 19,098
Contingent consideration $ 1,000 1,000
Derivative asset, statement of financial position Other non-current assets  
Fair Value, Recurring    
Assets:    
Total assets $ 216  
Liabilities:    
Private warrants 1,314 19,098
Contingent consideration 1,000 1,000
Total liabilities 2,314 20,098
Fair Value, Recurring | Committed Equity Facility    
Assets:    
Committed equity facility 216  
Level 1 | Fair Value, Recurring    
Assets:    
Total assets 0  
Liabilities:    
Private warrants 0 0
Contingent consideration 0 0
Total liabilities 0 0
Level 1 | Fair Value, Recurring | Committed Equity Facility    
Assets:    
Committed equity facility 0  
Level 2 | Fair Value, Recurring    
Assets:    
Total assets 0  
Liabilities:    
Private warrants 0 0
Contingent consideration 0 0
Total liabilities 0 0
Level 2 | Fair Value, Recurring | Committed Equity Facility    
Assets:    
Committed equity facility 0  
Level 3 | Fair Value, Recurring    
Assets:    
Total assets 216  
Liabilities:    
Private warrants 1,314 19,098
Contingent consideration 1,000 1,000
Total liabilities 2,314 $ 20,098
Level 3 | Fair Value, Recurring | Committed Equity Facility    
Assets:    
Committed equity facility $ 216